Product Details

Esomeprazole + Domperidone Tablets BP 50 mg deliver a high-quality combination therapy that meets British Pharmacopoeia (BP) standards. This fixed-dose combination manages gastroesophageal reflux disease (GERD) and related upper gastrointestinal disorders, combining acid suppression with improved gut motility in a single tablet.

The tablets combine:

• Esomeprazole, a proton pump inhibitor (PPI) that reduces stomach acid production and promotes healing of acid-related damage to the esophagus and stomach lining, and
• Domperidone, a prokinetic agent that enhances gastric motility and relieves nausea, vomiting, bloating, and early satiety.

Doctors commonly prescribe this combination for GERD, acid reflux with associated motility issues, dyspepsia, and other upper GI disorders. Hospitals, clinics, and pharmacies rely on this formulation for its consistent quality and dependable results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• BP-standard compliant combination therapy
• Treats GERD and acid reflux with associated motility issues
• Delivers both acid-suppressing and prokinetic effects
• Contains an accurate 50 mg dosage per tablet
• Maintains a high-purity, stable formulation
• Uses hygienic blister packaging for safe storage
• Suits hospital, clinical, and pharmacy use